Science 37 has been recognized with the prestigious Frost & Sullivan Market Leadership Award in the global decentralized clinical trials (DCT) industry. This acknowledgment highlights Science 37's accomplishments, and solidifies its role as an industry leader, as it continues to transform clinical trial conduct through the Metasite™.
Frost & Sullivan's Best Practices Market Leadership Award is bestowed upon companies that exhibit outstanding performance and visionary approaches in their respective industries. The receipt of this prestigious award highlights Science 37’s dedication to accelerating clinical research by enabling universal trial access for patients.
Science 37's unique approach is a virtual site, or Metasite, which enables patients to participate in clinical trials from the comfort of their homes.
To learn more about Frost & Sullivan’s analysis of the Metasite, fill out the form.